Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 2Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatosis 1 1Brain Neoplasms 1

Interventions

Saline Solution 6Dexmedetomidine 5Sodium Chloride 4Temozolomide 3Sevoflurane 3Propofol 3Methotrexate 3Levetiracetam 3trametinib 2perampanel 2dabrafenib 2Sugammadex 2Neuroimaging 2Methylphenidate 2Magnetic Resonance Spectroscopy 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gentamicins 2Fluorescein 2Anesthesia, Inhalation 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1pembrolizumab 1pegvisomant 1olutasidenib 1naxitamab 1lorlatinib 1gadoterate meglumine 1gadobenic acid 1durvalumab 1dexketoprofen trometamol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Methylphenidate × CNS × Clear all
NCT00576472 2017-05-30

Learning Impairments Among Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 4 Completed
469 enrolled 43 charts
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00169611 2011-01-27

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

Hospices Civils de Lyon

Phase 4 Completed
80 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡